We are live on
!
Find out more
OAM
Oxford Asset Management Portfolio holdings
AUM
$232M
1-Year Est. Return
31%
This Fund
S&P 500
This Quarter
Est. Return
+10.75%
1 Year Est. Return
+31%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$301M
AUM Growth
-$1.18M
(-0.39%)
Cap. Flow
-$8.83M
Cap. Flow
% of AUM
-2.93%
Top 10 Holdings %
Top 10 Hldgs %
14.18%
Holding
794
New
288
Increased
82
Reduced
51
Closed
368
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Freeport-McMoran
FCX
|
+$5.15M |
| 2 |
Comcast
CMCSA
|
+$3.58M |
| 3 |
General Mills
GIS
|
+$3.48M |
| 4 |
Ford
F
|
+$3.31M |
| 5 |
Nike
NKE
|
+$3.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$8.08M |
| 2 |
Adobe
ADBE
|
+$5.85M |
| 3 |
Accenture
ACN
|
+$4.4M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$2.66M |
| 5 |
Roblox
RBLX
|
+$2.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.54% |
| 2 | Technology | 13.7% |
| 3 | Consumer Discretionary | 12.23% |
| 4 | Financials | 11.94% |
| 5 | Industrials | 11.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Manitowoc
MTW
$678M
| $283K | 0.09% |
+28,309
| New | +$315K |
|
|
LBRX
352
LB Pharmaceuticals
LBRX
$1.31B
| $280K | 0.09% |
+17,763
| New | +$282K |
|
353
Nurix Therapeutics
NRIX
$2.69B
| $277K | 0.09% |
+29,952
| New | +$311K |
|
354
The RMR Group
RMR
$335M
| $275K | 0.09% |
+17,451
| New | +$292K |
|
|
SI
355
Shoulder Innovations Inc
SI
$430M
| $272K | 0.09% |
+21,634
| New | +$302K |
|
|
DAWN
356
DELISTED
Day One Biopharmaceuticals
DAWN
| $271K | 0.09% |
+38,463
| New | +$265K |
|
357
Gold Royalty Corp
GROY
$711M
| $269K | 0.09% |
+69,685
| New | +$215K |
|
358
Bausch + Lomb
BLCO
$6.01B
| $269K | 0.09% |
+17,822
| New | +$257K |
|
359
MidCap Financial Investment
MFIC
$797M
| $265K | 0.09% |
+22,066
| New | +$282K |
|
360
Amylyx Pharmaceuticals
AMLX
$2.53B
| $260K | 0.09% |
+19,120
| New | +$180K |
|
361
Tronox
TROX
$993M
| $259K | 0.09% |
+64,509
| New | +$295K |
|
362
Crescent Energy
CRGY
$4.03B
| $255K | 0.08% |
+28,565
| New | +$259K |
|
363
Columbus McKinnon
CMCO
$557M
| $251K | 0.08% |
+17,469
| New | +$263K |
|
364
AtaiBeckley Inc
ATAI
$2.68B
| $245K | 0.08% |
+46,382
| New | +$188K |
|
365
Gladstone Investment Corp
GAIN
$651M
| $245K | 0.08% |
+17,727
| New | +$250K |
|
366
Viemed Healthcare
VMD
$355M
| $242K | 0.08% |
+35,690
| New | +$242K |
|
|
VG
367
Venture Global Inc
VG
$35.4B
| $242K | 0.08% |
+17,075
| New | +$243K |
|
368
WisdomTree
WT
$3.36B
| $240K | 0.08% |
+17,255
| New | +$231K |
|
369
Petco
WOOF
$765M
| $235K | 0.08% |
+60,611
| New | +$203K |
|
370
Aquestive Therapeutics
AQST
$538M
| $232K | 0.08% |
+41,415
| New | +$179K |
|
371
Planet Labs
PL
$8.23B
| $231K | 0.08% |
17,832
+6,424
| +56% | +$49.6K |
|
|
XIFR
372
XPLR Infrastructure LP
XIFR
$1.07B
| $229K | 0.08% |
+22,515
| New | +$218K |
|
373
Stoneridge
SRI
$203M
| $223K | 0.07% |
+29,252
| New | +$232K |
|
374
NerdWallet
NRDS
$645M
| $215K | 0.07% |
+19,999
| New | +$213K |
|
|
KLC
375
KinderCare Learning Companies
KLC
$596M
| $210K | 0.07% |
31,665
-9,332
| -23% | -$78.3K |
|
Similar funds
KG
VOMP
TLA
RWS
SC
RWMG
TW
NTIC
Oxford Asset Management's Q3 2025 Portfolio in Review
As of Q3 2025, Oxford Asset Management held 794 positions worth $301M, down 0.39% from $302M the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Oxford Asset Management's Q3 2025 filing shows 288 new, 82 increased, 51 reduced and 368 closed positions. Its largest new stake was Comcast: 106,691 shares worth $3.35M. The largest sale was State Street SPDR S&P Biotech ETF, an estimated $8.08M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 12% a quarter earlier, followed by Technology and Consumer Discretionary.
- Oxford Asset Management's largest Q3 2025 buy was Comcast: 106,691 shares worth $3.35M.
- Oxford Asset Management added most to Freeport-McMoran in Q3 2025, an estimated $5.15M increase.
- Oxford Asset Management's biggest Q3 2025 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $8.08M.
- Oxford Asset Management fully exited Adobe in Q3 2025, selling an estimated $5.85M.
- Oxford Asset Management's ten largest holdings make up 14% of its $301M portfolio in Q3 2025.
- Oxford Asset Management opened 288 new positions and closed 368 in Q3 2025.
- Oxford Asset Management's portfolio value fell 0.39% quarter-over-quarter to $301M.
Based on Oxford Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.